Phenylketonuria : an inborn error of phenylalanine metabolism

R.A. Williams, C. Mamotte, John Burnett

    Research output: Contribution to journalReview articlepeer-review


    Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine (Phe) metabolism resulting from deficiency of phenylalanine hydroxylase (PAH). Most forms of PKU and hyperphenylalaninaemia (HPA) are caused by mutations in the PAH gene on chromosome 12q23.2. Untreated PKU is associated with an abnormal phenotype which includes growth failure, poor skin pigmentation, microcephaly, seizures, global developmental delay and severe intellectual impairment. However, since the introduction of newborn screening programs and with early dietary intervention, children born with PKU can now expect to lead relatively normal lives. A better understanding of the biochemistry, genetics and molecular basis of PKU, as well as the need for improved treatment options, has led to the development of new therapeutic strategies.
    Original languageEnglish
    Pages (from-to)31-41
    JournalThe Clinical Biochemist Reviews
    Issue number1
    Publication statusPublished - 2008


    Dive into the research topics of 'Phenylketonuria : an inborn error of phenylalanine metabolism'. Together they form a unique fingerprint.

    Cite this